Target intelligence / Profile preview

Lean body mass preservation via increased protein intake

Molecular classification
Other
01

Overview

"Lean body mass preservation via increased protein intake" is not a single molecule or receptor, but rather describes a physiological outcome—namely the maintenance or increase of skeletal muscle and other non-fat tissues through dietary strategies that emphasize higher or optimized levels of dietary protein. The underlying biological processes involve the stimulation of muscle protein synthesis and reduction in muscle protein breakdown, which are regulated by complex metabolic pathways responsive to both nutritional and exercise stimuli[1][2][3]. Key amino acids such as leucine play an important role in triggering anabolic signaling for new muscle proteins, particularly after resistance exercise or during recovery from catabolic states[1][2]. While clinical studies have examined whether increasing daily dietary protein above recommended levels preserves lean body mass—especially in older adults—the results are mixed; some trials show no significant benefit beyond standard recommendations unless combined with other interventions like resistance training or anabolic hormones[4]. This entry does not correspond to any canonical drug target such as an enzyme, receptor, transporter, or transcription factor. Summary: This is not a valid therapeutic target at the molecular level. It refers instead to a nutritional intervention strategy affecting whole-body physiology through multiple downstream targets involved in skeletal muscle metabolism.

Other names
Lean body mass preservation via increased protein intakeProtein intake for muscle maintenanceDietary protein and lean mass retention
02

Biological functions

Muscle protein synthesisMuscle protein breakdown regulationSkeletal muscle remodelingMaintenance of lean body mass
03

Disease associations

Sarcopenia (age-related muscle loss)Cachexia (muscle wasting in chronic disease)Frailty in elderly populationsOther conditions involving loss of lean body mass
04

Safety considerations

null (general concerns may include renal function with high-protein diets, but not specific to a molecular target)
05

Biomarkers

null (potentially serum urea nitrogen, urinary urea nitrogen as indirect markers of protein metabolism, but not specific to a molecular target)

Beyond the preview

Go deeper on Lean body mass preservation via increased protein intake.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lean body mass preservation via increased protein intake.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call